Clinical Trials Logo

Autistic Disorder clinical trials

View clinical trials related to Autistic Disorder.

Filter by:

NCT ID: NCT06255925 Recruiting - Autism Clinical Trials

A Strength-Based Employment Maintenance Program for Individuals on the Autism Spectrum

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The investigators are looking to evaluate how effective a training program that focuses on character strengths may be in improving job maintenance skills in young adults. The investigators are examining the effects of this intervention in young adults who feel they would like to help in improving their satisfaction with work, and in keeping their jobs.

NCT ID: NCT06247176 Recruiting - Clinical trials for Autism Spectrum Disorder

Sensory Habituation in Autism Spectrum Disorders

ASD_VR_RE
Start date: January 8, 2024
Phase: N/A
Study type: Interventional

Autism spectrum disorder (ASD) is one of the most common developmental disabilities and often people with ASD have sensory processing disorders. These sensory processing disorders are often associated with problem behaviors and, more recently, have been connected to anxiety disorders in people with ASD. While it has been suggested that sensory processing responses in ASD could be malleable, current treatment strategies for sensory processing disorders in ASD have inconsistent results or lack large-sample sized data. This investigation will explore changes in neurophysiological activity in people with ASD and neurotypical peers after they are exposed to an unpleasant visual stimulus through a virtual reality systematic desensitization protocol. 30 people with ASD and 30 neurotypical people between the ages 7 - 35 will be recruited. The study have, 1) a practice magnetic resonance imaging (MRI) visit with questionnaires, 2) a per-exposure MRI with structural and functional MRI collections, 3) a virtual reality systematic desensitization session where we will record the participant's physiological response using an Emotibit device, and 4) a post-exposure MRI session with structural and functional MRI collections. This investigation aims to quantify changes in neurophysiological responses in order to determine the effect of systematic desensitization.

NCT ID: NCT06246487 Recruiting - Clinical trials for Autism Spectrum Disorder

Sensory Intervention for Children With Autism

Start date: January 16, 2024
Phase: N/A
Study type: Interventional

Greater than 80% of children with autism spectrum disorder (ASD) experience sensory differences that make it difficult for them to fully participate in meaningful everyday activities. In this research study, we will use MRI and behavioral methods to assess how sensory interventions might change sensory brain structures, allowing us to better predict which sensory interventions might work best for whom.

NCT ID: NCT06233279 Recruiting - Clinical trials for Autism Spectrum Disorder

Study of Application of Transcutaneous Trigeminal Nerve Stimulation on Autism Spectrum Disorder

Start date: November 15, 2022
Phase: N/A
Study type: Interventional

This study aims to evaluate the safety and the efficacy of applying transcutaneous trigeminal nerve stimulator (NuEyne P01) on autism spectrum disorder.

NCT ID: NCT06227780 Recruiting - Clinical trials for Autism Spectrum Disorder

Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders

ENTRAIN
Start date: May 24, 2023
Phase: N/A
Study type: Interventional

Fragile X Syndrome (FXS) is a complex neurodevelopmental disorder caused by a mutation on the X chromosome. Scientists have investigated FXS extensively in both humans and animals. Thus far, phenotypic rescue in animal models has not resulted in treatment breakthroughs in humans, though some important discoveries have been made. Research has shown that individuals with FXS process sounds differently than those in the typical population, and they also show baseline differences in brain activity, including high gamma activity, increased theta activity, and decreased alpha activity. The investigators' central hypothesis is that these alterations in brain activity (specifically alpha and gamma activity) impair the brain's ability to process new information, thereby impeding cognitive functioning and increasing sensory sensitivity. The investigators propose that auditory entrainment, a technique that involves playing special sounds through headphones, will normalize brain activity in individuals with FXS and lead to increased cognitive function and decreased sensory hypersensitivity.

NCT ID: NCT06221176 Recruiting - Clinical trials for Autism Spectrum Disorder

Biomarkers Research in Anxiety for Validation and Efficacy

BRAVE
Start date: April 2, 2024
Phase: N/A
Study type: Interventional

A within-subjects design will be used for this preliminary investigation of four biomarkers across two contexts of use: prediction of treatment response (i.e., stratification) and quantification of response (i.e., change).

NCT ID: NCT06214065 Recruiting - Clinical trials for Autism Spectrum Disorder

Modulating Temporoparietal Junction Mentalizing-Related Activity in Autism Spectrum Disorder (ASD) Using Transcranial Magnetic Stimulation (TMS)

Start date: April 3, 2024
Phase: N/A
Study type: Interventional

The goal of this observational study is to test the modulation effect of different transcranial magnetic stimulation (TMS) on the neural network supporting our ability to create mental representations of others (also known as mentalizing) in young adults with autism. The main question it aims to answers is can stimulation of the right temporoparietal junction can change brain activity related to mentalizing during social interaction in the stimulation area and other brain areas connected to it. Researchers will compare results to a group of individuals without autism to see if the patterns of neural activity change are similar between the groups. Participants will undergo assessment of their clinical traits and social skills and baseline MRI scan. They will attend three additional visits that include TMS session and functional MRI scans before and right after TMS.

NCT ID: NCT06208722 Recruiting - Autism Clinical Trials

Testing a Mobile App to Improve Toothbrushing Skills and Habits in Teens With Autism

Start date: January 9, 2024
Phase: N/A
Study type: Interventional

The goal of this proposed trial will modify an existing toothbrushing app for teens with autism and compare toothbrushing outcomes with a control app. We have 2 specific aims: - During the 2-year UG3 phase, we will use the Discover, Design+Build, and Test Framework to modify our existing app and pilot the intervention. - During the 4-year UH3 phase, we will recruit 270 pre-adolescents and teens with autism ages 10 to 17 years, randomize participants to one of two arms, and compare outcomes. Participants will asked to use the app, complete surveys on REDCap, participate in feedback interviews and focus groups. Behavior change in the experimental group will be compared with that in the control group.

NCT ID: NCT06206070 Recruiting - Clinical trials for Autism Spectrum Disorder

The Westmead Feelings Program Intervention for Chinese Children With Autism Spectrum Disorder in Hong Kong

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

The goal of this intervention is to evaluate the effectiveness of delivering the Westmead Feelings Program 2 to children with Autism Spectrum Disorder in primary schools in Hong Kong.

NCT ID: NCT06196060 Recruiting - Clinical trials for Autism Spectrum Disorder

Improving ToM in Children With ASD Through VPT Training: Behavioral and fNIRS Study

Start date: November 15, 2023
Phase: N/A
Study type: Interventional

This study aims to employ a longitudinal tracking research to investigate the effects of a visual perspective taking intervention on the development of theory of mind in children with autism. Additionally, the investigators seek to examine modifications in the neural mechanisms linked to facial emotion recognition in children both before and after intervention by using the functional Near-Infrared Spectroscopy (fNIRS) to record the relative changes in blood oxygen levels in the cerebral cortex with the oddball Face-Periodic Visual Stimulation (FPVS) paradigm.